Cell Reports Medicine (Jun 2021)
Cytokine therapy in necrotizing enterocolitis: A promising treatment for preterm infants
Abstract
Necrotizing enterocolitis (NEC) is an intestinal disorder that disproportionately affects premature infants and lacks in effective therapeutics. Mihi and colleagues1 demonstrated that the cytokine interleukin-22 promotes intestinal epithelial regeneration and reduces disease severity in an experimental model of NEC.